综述 |
|
|
|
|
生物转化—从全细胞催化到代谢工程 |
郭明,胡昌华** |
西南大学药学院现代生物医药研究所 重庆 400716 |
|
Biotransformation—From Whole-cell Biocatalysis To Metabolic Engineering |
GUO Ming,HU Chang-hua |
Institute of Modern Biopharmaceuticals, School of Pharmaceutical Sciences,Southwest University,Chongqing 400716,China |
[1] Schoemaker H E,Mink D,Wubbolts M G. Dispelling the myths Biocatalysis in industrial synthesis. Science,2003,299(5613): 16941697.
[2] Yu H M, Yin J. Construction and selection of the novel recombinant Escherichia coli strain for poly(betahydroxybutyrate) production. Journal of Bioscience and Bioengineering,2000,89(4): 307311.
[3] De Carvalho C,Da Fonseca M. Biotransformation of terpenes. Biotechnology Advances,2006,24(2): 134142.
[4] Dai J G,Qu R J,Zou J H,et al. Structural diversification of taxanes by wholecell biotransformation. Tetrahedron,2008,64(35): 81028116.
[5] Peng Y L,Demain A L. Bioconversion of compactin to pravastatin by Actinomadura sp. ATCC 55678. Journal of Molecular Catalysis B: Enzymatic,2000,10(13): 151156.
[6] Park J W,Lee J K,Kwon T J,et al. Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnology Letters,2003,25(21): 18271831.
[7] Wang F Q,Li B,Wang W,et al. Biotransformation of diosgenin to nuatigenintype steroid by a newly isolated strain,Streptomyces virginiae IBL14. Applied Microbiology and Biotechnology,2007,77: 771777.
[8] Ghosh S,Sachan A,Sen S K,et al. Microbial transformation of ferulic acid to vanillic acid by Streptomyces sannanensis MTCC 6637. Journal of Industrial Microbiology & Biotechnology,2007,34(2): 131138.
[9] Liu J H,Chen Y G,Yu B Y,et al. A novel ketone derivative of artemisinin biotransformed by Streptomyces griseus ATCC 13273. Bioorganic & Medicinal Chemistry Letters,2006,16(7): 19091912.
[10] Faramarzi M A,Aghelnejad M,TabatabaeiYazdi M,et al. Metabolism of androst4en3,17dione by the filamentous fungus Neurospora crassa. Steroids, 2008,73: 1318.
[11] Choudhary M I,Khan N T,Musharraf S G,et al. Biotransformation of adrenosterone by filamentous fungus, Cunninghamella elegans. Steroids,2007,72: 923929.
[12] Dong J Y,Chen Y G,Song H C,et al. Hydroxylation of the triterpenoid nigranoic acid by the fungus Gliocladium roseum YMF1.00133. Chemistry & Biodiversity,2007,4(2): 112117.
[13] Luetz S,Giver L,Lalonde J. Engineered enzymes for chemical production. Biotechnology and Bioengineering,2008,101(4):647653.
[14] Pollard D J,Woodley J M. Biocatalysis for pharmaceutical intermediates: the future is now. Trends in Biotechnology,2007,25(2):6673.
[15] Xie X K,Tang Y.Efficient synthesis of simvastatin by use of wholecell biocatalysis.Applied and Environmental Microbiology,2007,73(7): 20542060.
[16] Xie X K,Watanabe K,Wojcicki W A,et al. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chemistry and Biology, 2006,13: 11611169.
[17] Xie X K,Wong W W,Tang Y.Improving simvastatin bioconversion in Escherichia coli by deletion of bioH. Metabolic Engineering,2007,9(4): 379386.
[18] Gao X,Xie X K,Pashkov I,et al. Directed evolution and structural characterization of a simvastatin synthase. Chemistry and Biology,2009,16(10):10641074.
[19] Fujii T,Narikawa T,Sumisa F,et al. Production of alpha,omegaalkanediols using Escherichia coli expressing a cytochrome p450 from Acinetobacter sp OC4. Bioscience Biotechnology and Biochemistry,2006,70(6): 13791385.
[20] Shrestha P,Oh T J,Sohng J K. Designing a wholecell biotransformation system in Escherichia coli using cytochrome P450 from Streptomyces peucetius. Biotechnology Letters,2008,30(6): 11011106.
[21] Kau P B,BringerMeyer S,Sahm H. Dmannitol formation from Dglucose in a wholecell biotransformation with recombinant Escherichia coli. Applied Microbiology and Biotechnology,2005,69(4): 397403.
[22] Cirino P C,Chin J W,Ingram L O. Engineering Escherichia coli for xylitol production from glucosexylose mixtures. Biotechnology and Bioengineering, 2006,95(6):11671176.
[23] Overhage J,Steinbuchel A,Priefert H. Highly efficient biotransformation of eugenol to ferulic acid and further conversion to vanillin in recombinant strains of Escherichia coli. Applied and Environmental Microbiology,2003, 69(11): 65696576.
[24] Payne M S,Petrillo K L,Gavagan J E,et al. Highlevel production of spinach glycolate oxidase in the methylotrophic yeast Pichia pastoris: Engineering a biocatalyst. Gene,1995,167(12): 215219.
[25] Sauerzapfe B,Engels L,Elling L. Broadening the biocatalytic properties of recombinant sucrose synthase 1 from potato (Solanum tuberosum L.) by expression in Escherichia coli and Saccharomyces cerevisiae. Enzyme and Microbial Technology ,2008,43: 289–296.
[26] Honda K,Tsuboi H,Minetoki T,et al. Expression of the Fusarium oxysporum lactonase gene in Aspergillus oryzae: molecular properties of the recombinant enzyme and its application. Applied Microbiology and Biotechnology, 2005,66(5): 520526.
[27] Chun H K,Ohnishi Y,Shindo K,et al. Biotransformation of flavone and flavanone by Streptomyces lividans cells carrying shuffled biphenyl dioxygenase genes. Journal of Molecular Catalysis BEnzymatic,2003,21(3): 113121.
[28] StutzmanEngwall K,Conlon S,Fedechko R,et al. Semisynthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis. Metabolic Engineering,2005,7(1): 2737.
[29] Jager S,Jekel PA,Janssen D B. Hybrid penicillin acylases with improved properties for synthesis of betalactam antibiotics. Enzyme and Microbial Technology,2007,40(5): 13351344.
[30] Gillam E M J. Extending the capabilities of nature’s most versatile catalysts: Directed evolution of mammalian xenobioticmetabolizing P450s. Archives of Biochemistry and Biophysics,2007,464(2): 176186.
[31] Tyo K E,Alper H S,Stephanopoulos G N. Expanding the metabolic engineering toolbox: more options to engineer cells. Trends in Biotechnology, 2007,25(3): 132137.
[32] Kau PB,BringerMeyer S,Sahm H. Metabolic engineering of Escherichia coli:construction of an efficient biocatalyst for Dmannitol formation in a wholecell biotransformation. Applied Microbiology and Biotechnology,2004,64:333339.
[33] Nguyen H T T,Nevoigt E. Engineering of Saccharomyces cerevisiae for the production of dihydroxyacetone (DHA) from sugars: A proof of concept. Metabolic Engineering,2009,11(6):335346.
[34] Mojzita D,Wiebe M,Hilditch S,et al. Metabolic engineering of fungal strains for conversion of Dgalacturonate to mesogalactarate. Applied and Environmental Microbiology,2010,76(1):169175.
[35] Stafford D E,Yanagimachi K S,Lessard PA,et al. Optimizing bioconversion pathways through systems analysis and metabolic engineering. Proceedings of the National Academy of Sciences of the United States of America, 2002,99(4): 18011806.
[36] Chung K B S,Lee D Y. Fluxsum analysis: a metabolitecentric approach for understanding the metabolic network. BMC Systems Biology,2009,117(3):110.
[37] Cakir T,Arga K Y,Altintas M M,et al. Flux analysis of recombinant Saccharomyces cerevisiae YPBG utilizing starch for optimal ethanol production. Process Biochemistry,2004,39(12): 20972108.
[38] Atsumi S,Cann A F,Connor M R,et al. Metabolic engineering of Escherichia coli for 1butanol production. Metabolic Engineering,2008,10(6):305311.
[39] Mukherji S,van Oudenaarden A. Synthetic biology: understanding biological design from synthetic circuits. Nature Reviews Genetics,2009,10(12):859871.
[40] Puchalka J,Oberhardt M A,Godinho M,et al. Genomescale reconstruction and analysis of the Pseudomonas putida KT2440 metabolic network facilitates applications in biotechnology. Plos Computational Biology, 2008,4(10):118. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|